AJMC --- spirometric requirement getting resolved?

[mssciguy]

Is Sanofi going to try steering patients who want Afrezza to docs with spirometers?  Would seem to fit with their 1-800 number for patient support... what a lovely work-around that would be.  I know that some MDs including my own, don't have an extra minute to spare.

"Officially, Sanofi does not see spirometry as a challenge to broader use of the drug. “While spirometry testing is required in order for a patient to be prescribed Afrezza, we do not see this as a barrier since many healthcare professionals are familiar with and have spirometry equipment in their offices,” said Susan Brooks, spokeswoman for Sanofi Diabetes, in an email to Evidence-Based Diabetes Management. “We have and will continue to make sure to get feedback and input from healthcare professionals and patients to help make Afrezza available to appropriate patients.” - See more at: www.ajmc.com/journals/evidence-based-diabetes-management/2015/july-2015/sanofi-addresses-need-for-spirometry-before-physicians-can-prescribe-afrezza#sthash.CfsrpzDA.dpuf

[figglebird]

Label Changes are FAR MORE beneficial at this moment then spirometry requirement alone.

[mssciguy]

Aug 18, 2015 14:21:26 GMT -5 figglebird said:

Label Changes are FAR MORE beneficial at this moment then spirometry requirement alone.

Like this?  dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=76fb46f1-82db-40da-ba19-b3a7b0bd78ff#S16

[ezrasfund]

Hakan made an interesting distinction during the last CC. Spirometry issues may delay someone getting an Afrezza scrip, but it will not prevent them from getting Afrezza in the way that insurance issues are blocking diabetic from using Afrezza. I guess a short delay doesn't matter that much to SNY and MNKD if they have a lifelong customer.